Company intelligence
Evinova
Global healthtech
About Evinova
Digital solutions need to do more to propel clinical development, elevate user experiences and accelerate better health outcomes. At Evinova, we’re doing something about it. We’re a healthtech business, with globally-scaled digital products that have proven benefits for sponsors, sites and patients. We've accelerated timelines, improved patient experiences, reduced costs, and minimised carbon footprints across hundreds of clinical studies. Evinova is a 300+ person strong team offering digital solutions to pharma, biotech and CROs to support clinical research globally. Community Guidelines: http://bit.ly/3JIeErQ
Verified activity
Signals from Evinova
13 published signals
Research & Knowledge
Evinova found that 50% fewer patients were needed in a Phase II COPD study compared to a traditional design.
Reported by Evinova
Research & Knowledge
Evinova found that 50% fewer in-person visits were needed in the Phase II COPD study.
Reported by Evinova
Research & Knowledge
Evinova conducted a Phase II COPD study using a remote connected spirometer paired with AI-validated overreads and the CompEx digital endpoint to enable live, continuous monitoring instead of a fixed observation schedule.
Reported by Evinova
Research & Knowledge
Evinova achieved a $8m reduction in study costs in the Phase II COPD study.
Reported by Evinova
Research & Knowledge
Evinova achieved 6 months faster study completion in the Phase II COPD study.
Reported by Evinova
Presence & Recognition
Evinova hosted a cross-industry workshop at European Respiratory Society bringing together top leaders from AstraZeneca, Boehringer Ingelheim, Genentech, GSK, J&J, MSD, Sanofi, and patient and research networks like IREN and GAAPP and KOLs like Paul Jones.
Reported by Cristina Ortega Duran
Research & Knowledge
Evinova published a case study on the ERS2026 respiratory trials showing that the Unified Trial Solution connected patients and sites through a single app and portal with ~60% of visits completed from home.
Reported by Evinova
Partnerships
Evinova introduced a new partnership with Lothar Medical to offer sponsors a comprehensive respiratory trial approach combining patient-reported outcomes, real-time data, novel endpoints, and Lothar Medical's 3-in-1 device for spirometry, FeNO, and oscillometry.
Reported by Evinova
People
Evinova welcomed Tim Harrison as Chief Medical Officer (CMO) of the company.
Reported by Cristina Ortega Duran
Products & Services
Evinova launched into ERS Barcelona.
Reported by David Friend
Presence & Recognition
Evinova will host the 4th Annual Clinical Trials in Rare Diseases 2026 event featuring the European Respiratory Society Congress and the DPHARM Clinical Trial Supply Event Series in the West Coast.
Reported by Evinova
Presence & Recognition
Evinova will be attending the DPHARM conference in two weeks
Reported by Abbe Macbeth, PhD
People
Evinova is looking for Senior Cloud Engineers with experience building reliable infrastructure for agents at scale to grow its ML/AI Operations team.
Reported by Peter N.